HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Praveen Anand Selected Research

Hematuria

7/2006Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations.
3/2006Cool and menthol receptor TRPM8 in human urinary bladder disorders and clinical correlations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Praveen Anand Research Topics

Disease

31Pain (Aches)
01/2022 - 01/2002
16Neuralgia (Stump Neuralgia)
10/2021 - 01/2004
11Hypersensitivity (Allergy)
11/2023 - 04/2005
8Chronic Pain
04/2021 - 08/2007
7Inflammation (Inflammations)
06/2014 - 01/2004
6Neoplasms (Cancer)
01/2022 - 01/2019
5Diabetic Neuropathies (Diabetic Neuropathy)
01/2022 - 01/2004
5Hyperalgesia
10/2015 - 01/2004
4Peripheral Nervous System Diseases (PNS Diseases)
01/2022 - 01/2019
4Interstitial Cystitis (Interstitial Cystitis, Chronic)
12/2006 - 03/2006
3Postherpetic Neuralgia
10/2021 - 05/2014
3COVID-19
01/2021 - 01/2020
3Arthritis (Polyarthritis)
09/2018 - 08/2011
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 02/2003
2Multiple Myeloma
04/2024 - 01/2022
2Multiple Sclerosis
09/2018 - 06/2010
2Nociceptive Pain
01/2016 - 04/2009
2Burning Mouth Syndrome (Syndrome, Burning Mouth)
08/2010 - 06/2010
2Abdominal Pain (Pain, Abdominal)
06/2010 - 02/2003
2Neuroma
09/2008 - 01/2006
2Rhinitis
04/2008 - 09/2007
2Allergic Rhinitis
04/2008 - 09/2007
2Hematuria
07/2006 - 03/2006
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2023
1Hypoxia (Hypoxemia)
01/2021
1Cold Injury
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Myalgia
01/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Headache (Headaches)
01/2021
1Fatigue
01/2021
1Infections
01/2020
1Somatoform Disorders (Somatoform Disorder)
09/2018
1Cancer Pain
09/2018
1Weight Loss (Weight Reduction)
01/2018
1Phantom Limb (Phantom Limbs)
01/2017
1Pruritus (Itching)
05/2015
1Psoriasis (Pustulosis Palmaris et Plantaris)
05/2015
1Radiculopathy (Radiculopathy, Cervical)
04/2015

Drug/Important Bio-Agent (IBA)

17Capsaicin (Zostrix)FDA Link
11/2023 - 04/2004
8Nerve Growth Factor (NGF)IBA
01/2021 - 01/2004
7Analgesics (Analgesic Drugs)IBA
10/2021 - 08/2007
6Voltage-Gated Sodium ChannelsIBA
10/2018 - 01/2002
6TRPV Cation ChannelsIBA
01/2018 - 09/2004
5Proteins (Proteins, Gene)FDA Link
01/2020 - 09/2007
5Ion Channels (Ion Channel)IBA
05/2015 - 11/2007
5AntibodiesIBA
04/2008 - 02/2003
4Type 2 Angiotensin ReceptorIBA
10/2021 - 05/2014
4EMA400IBA
10/2021 - 05/2014
4TRPV1 receptorIBA
01/2020 - 04/2004
3RNA (Ribonucleic Acid)IBA
01/2021 - 01/2020
3Biomarkers (Surrogate Marker)IBA
01/2021 - 08/2007
3Sodium Channels (Sodium Channel)IBA
01/2011 - 04/2008
2NAD (NADH)IBA
01/2022 - 01/2021
2CannabinoidsIBA
04/2021 - 06/2010
2Small Cytoplasmic RNAIBA
01/2021 - 01/2020
2Therapeutic UsesIBA
01/2020 - 01/2006
2Nerve Growth Factors (Neurotrophins)IBA
01/2020 - 01/2004
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2020 - 01/2004
2Peptides (Polypeptides)IBA
01/2020 - 01/2016
2Angiotensin IIIBA
02/2016 - 06/2015
2LigandsIBA
01/2016 - 06/2015
2p38 Mitogen-Activated Protein KinasesIBA
04/2015 - 11/2011
2Cannabinoid Receptors (Cannabinoid Receptor)IBA
06/2010 - 09/2008
1Terpenes (Terpenoids)IBA
11/2023
1Triglycerides (Triacylglycerol)IBA
10/2023
1ElectrolytesIBA
10/2023
1Cell-Free Nucleic AcidsIBA
01/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1ChromatinIBA
11/2021
1Medical MarijuanaIBA
04/2021
1Dronabinol (THC)FDA LinkGeneric
01/2021
1Calcium Gluconate (CBG)IBA
01/2021
1VaccinesIBA
01/2021
1HLA-A Antigens (HLA-A)IBA
01/2020
1Nucleic AcidsIBA
01/2020
1CannabidiolIBA
01/2020
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2018
1Purinergic AgonistsIBA
01/2018
1Glucagon-Like Peptide-1 ReceptorIBA
01/2018
1Adenosine Triphosphate (ATP)IBA
01/2018
1Angiotensin II Type 2 Receptor BlockersIBA
02/2016
1NociceptinIBA
01/2016
1Peptide Receptors (Peptide Receptor)IBA
01/2016
1Opioid Receptors (Opioid Receptor)IBA
01/2016
1GAP-43 Protein (GAP 43 Protein)IBA
10/2015
1AntigensIBA
10/2015
1pegcantratinibIBA
05/2015
1TropomyosinIBA
05/2015
16- amino- 5- (2,3,5- trichlorophenyl)pyridine- 2- carboxylic acid methylamideIBA
05/2015
1Phosphotransferases (Kinase)IBA
05/2015
1CalciumIBA
05/2015
16- (5- ((cyclopropylamino)carbonyl)- 3- fluoro- 2- methylphenyl)- N- (2,2- dimethylprpyl)- 3- pyridinecarboxamideIBA
04/2015

Therapy/Procedure

8Therapeutics
04/2024 - 01/2002
4Drug Therapy (Chemotherapy)
01/2021 - 08/2008
2Analgesia
02/2016 - 01/2004
1Precision Medicine
12/2021
1Aftercare (After-Treatment)
01/2021
1Surgical Amputation (Amputations)
01/2017
1Prostheses and Implants (Prosthesis)
01/2017